Clinical Trial Results: A Study of Tiragolumab Plus Atezolizumab Compared With Placebo Plus Atezolizumab in Participants With Completely Resected Non-small Cell Lung Cancer Who Have Received Adjuvant Platinum-based Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 study evaluating tiragolumab plus atezolizumab versus placebo plus atezolizumab in completely resected NSCLC after adjuvant platinum chemotherapy; trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Drugs mentioned

• Atezolizumab (atezolizumab)
• Tiragolumab (tiragolumab)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Non-small Cell Lung Cancer (NSCLC) | Phase 3 | Status: TERMINATED | Results posted: 2026-06-10